FDA plans to change rules on approving Alzheimer’s drugs

http://www.nytimes.com/2013/03/14/health/fda-to-ease-alzheimers-drug-approval-rules.html?pagewanted=all&_r=0

The Food and Drug Administration (FDA) has published a proposal for public comment containing changes to its rules for approving new drugs for Alzheimer’s. The proposed changes reflect the trend in the Alzheimer’s field toward testing drugs earlier in the course of the disease. Under the new proposal, drugs in Alzheimer’s clinical trials might qualify for approval if people improved their performance on memory or reasoning tests but not necessarily tests of everyday activities.
Read the article >>

http://www.optimumseniorcare.com/services/alzheimerscare.php

http://optimumseniorcare.com/blog/